Literature DB >> 11276012

Differences in susceptibility to colonic stem cell somatic mutation in three strains of mice.

M Kuraguchi1, H Cook, E D Williams, G A Thomas.   

Abstract

Different species and different strains of animals commonly show very different sensitivities to carcinogenic regimes, which are often unexplained. A major possible contributory factor is variation in susceptibility to mutation, but this has not been directly demonstrated. This study therefore quantified the colonic stem cell mutation frequency in three strains of mice using two carcinogens. Stem cell mutations were identified using loss of function of glucose 6-phosphate dehydrogenase (G6PD) in individual crypts, a technique validated by several previous studies. The carcinogens dimethylhydrazine (DMH) and ethyl nitrosurea (ENU) were given to Balb/C, C57BL/6J, and C3H mice. In response to DMH, Balb/C mice were most susceptible, with approximately double the stem cell mutation frequency found in C3H and more than ten-fold that found in C57BL/6J (3.3+/-0.71 vs. 1.5+/-0.52 vs. 0.28+/-0.8x10(-4)). In response to ENU, Balb/C mice and C3H mice were equally susceptible, showing a stem cell mutation frequency approximately twice that of C57BL/6J (3.1+/-0.4 vs. 3.1+/-0.65 vs. 1.63+/-0.28x10(-4)). The observed differences among the strains with respect to somatic mutation following DMH treatment are likely to be due to the previously documented differences in metabolic conversion to the active metabolite. However, as ENU is a directly acting, rapidly inactivated mutagen, strain differences in response to ENU are unlikely to be due to strain-dependent metabolism of the mutagen and are likely to reflect differences in DNA repair efficiency, or possibly in stem cell kinetics among the strains studied. Susceptibility to the induction of colonic stem cell mutation is an important factor in susceptibility to carcinogens, whether due to differences in DNA repair or to other factors. Direct quantification of stem cell mutation frequency allows the separate identification of this component of the carcinogenic cascade and shows that it can make a major contribution to the differing susceptibility of different mouse strains. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11276012     DOI: 10.1002/path.834

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

1.  Investigation of Musashi-1 expressing cells in the murine model of dextran sodium sulfate-induced colitis.

Authors:  Tadahisa Fukui; Hiroaki Takeda; Hong-Jin Shu; Katsuyoshi Ishihama; Sayaka Otake; Yasukuni Suzuki; Shoichi Nishise; Nanami Ito; Takeshi Sato; Hitoshi Togashi; Sumio Kawata
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

2.  Quantification of Colonic Stem Cell Mutations.

Authors:  Ryan D Whetstone; Barry Gold
Journal:  J Vis Exp       Date:  2015-09-25       Impact factor: 1.355

3.  Optimization of a murine immunization model for study of PF4/heparin antibodies.

Authors:  S Suvarna; R Qi; G M Arepally
Journal:  J Thromb Haemost       Date:  2009-02-24       Impact factor: 5.824

4.  Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice.

Authors:  Jeremy J Bearss; Melissa Hunter; Jennifer L Dankmeyer; Kristen A Fritts; Christopher P Klimko; Chris H Weaver; Jennifer L Shoe; Avery V Quirk; Ronald G Toothman; Wendy M Webster; David P Fetterer; Joel A Bozue; Patricia L Worsham; Susan L Welkos; Kei Amemiya; Christopher K Cote
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

5.  o-Aminoazotoluene, 7,12-dimethylbenz[a]anthracene, and N-ethyl-N-nitrosourea, which are mutagenic but not carcinogenic in the colon, rapidly induce colonic tumors in mice with dextran sulfate sodium-induced colitis.

Authors:  Atsushi Hakura; Naoki Koyama; Yuki Seki; Jiro Sonoda; Shoji Asakura
Journal:  Genes Environ       Date:  2022-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.